DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
| Cas No.: | 77307-50-7 |
| Chemical Name: | 2-(4-Hydroxyphenyl)-3-(3-O,4-O-diacetyl-α-L-rhamnopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one |
| Synonyms: | SL-0101-1,SL0101-1,SL-0101,SL 0101,SL0101,SL0101 1 |
| SMILES: | C[C@H]1C(C([C@H](C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C |
| Formula: | C25H24O12 |
| M.Wt: | 516.453 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | SL 0101-1 is a selective inhibitor of p90 Rsk (ribosomal S6 kinase) (IC50 = 89 nM for Rsk-2). This product does not inhibit upstream kinases such as MEK, Raf and PKC. SL 0101-1 inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line. For the detailed information of SL 0101-1, the solubility of SL 0101-1 in water, the solubility of SL 0101-1 in DMSO, the solubility of SL 0101-1 in PBS buffer, the animal experiment (test) of SL 0101-1, the cell expriment (test) of SL 0101-1, the in vivo, in vitro and clinical trial test of SL 0101-1, the EC50, IC50,and affinity,of SL 0101-1, For the detailed information of SL 0101-1, the solubility of SL 0101-1 in water, the solubility of SL 0101-1 in DMSO, the solubility of SL 0101-1 in PBS buffer, the animal experiment (test) of SL 0101-1, the cell expriment (test) of SL 0101-1, the in vivo, in vitro and clinical trial test of SL 0101-1, the EC50, IC50,and affinity,of SL 0101-1, Please contact DC Chemicals. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|